Experience in Evaluating Drug Efficacy in a Bleomycin-Induced IPF Model
Today, we would like to introduce the modalities and target molecules that we have experience in evaluating drug efficacy in our bleomycin-induced IPF model.
SMC Laboratories has over 150 studies of experience in conducting IPF studies. As shown in the figure below, we have experience with test substances of various modalities, including small molecules, antibodies, peptides, nucleic acids, and cell therapy, and can handle them according to modality.
We have experience in evaluating target molecules, primarily related to fibrosis, inflammation, and immunity, and are available for extensive discussions. Below are some of the typical target molecules we have experience with.
Table. Target molecules evaluated for drug efficacy by the SMC’s IPF model (selected excerpts)
Why not use this model to conduct a drug efficacy evaluation study of your test substance?
If you would like to learn more about our IPF model services, please feel free to contact us.